Stock DNA
Pharmaceuticals & Biotechnology
CNY 3,213 Million (Small Cap)
NA (Loss Making)
NA
2.02%
0.08
-7.34%
1.69
Revenue and Profits:
Net Sales:
118 Million
(Quarterly Results - Sep 2025)
Net Profit:
-59 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.54%
0%
-17.54%
6 Months
-23.13%
0%
-23.13%
1 Year
-41.87%
0%
-41.87%
2 Years
-60.59%
0%
-60.59%
3 Years
-10.84%
0%
-10.84%
4 Years
-42.46%
0%
-42.46%
5 Years
-50.08%
0%
-50.08%
Dirui Industrial Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-6.77%
EBIT Growth (5y)
-186.99%
EBIT to Interest (avg)
33.49
Debt to EBITDA (avg)
7.95
Net Debt to Equity (avg)
0.07
Sales to Capital Employed (avg)
0.46
Tax Ratio
100.00%
Dividend Payout Ratio
49.96%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.52%
ROE (avg)
11.82%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.75
EV to EBIT
-27.89
EV to EBITDA
-46.40
EV to Capital Employed
1.72
EV to Sales
5.13
PEG Ratio
NA
Dividend Yield
1.90%
ROCE (Latest)
-6.18%
ROE (Latest)
-2.65%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
118.10
297.20
-60.26%
Operating Profit (PBDIT) excl Other Income
-77.50
41.80
-285.41%
Interest
3.50
2.00
75.00%
Exceptional Items
1.10
0.00
Consolidate Net Profit
-58.90
27.30
-315.75%
Operating Profit Margin (Excl OI)
-656.20%
100.20%
-75.64%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is -60.26% vs -15.97% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -315.75% vs -62.34% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,209.30
1,366.80
-11.52%
Operating Profit (PBDIT) excl Other Income
151.40
288.80
-47.58%
Interest
9.80
11.00
-10.91%
Exceptional Items
-4.00
-1.60
-150.00%
Consolidate Net Profit
141.90
275.60
-48.51%
Operating Profit Margin (Excl OI)
87.30%
180.10%
-9.28%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -11.52% vs 12.95% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -48.51% vs 5.27% in Dec 2023
About Dirui Industrial Co., Ltd. 
Dirui Industrial Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






